Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
腫瘍、後天性免疫不全症候群および白血病の二重免疫バイオスティミュレーションによる処置における使用のための治療剤
Document Type and Number:
Japanese Patent JP6804984
Kind Code:
B2
Abstract:
A composition for human and animal use as a therapy for the treatment of tumors, acquired immunodeficiency syndrome and leukemias is described. The composition, for human and animal use as an antitumor agent, has a strain of bacteria Lactobacillus reuteri LRE 03 DSM 23879 which is able to strongly stimulate the production of pro-inflammatory cytokines (Th1) interferon INF-gamma, the cytokines exhibiting a marked antitumor activity, and/or a strain of bacteria Lactobacillus salivarius LS06 DSM 26037 which is able to strongly stimulate the production of dendritic cells, the dendritic cells also exhibiting a marked antitumor activity.

Inventors:
Giovanni MOGNA
Application Number:
JP2016566657A
Publication Date:
December 23, 2020
Filing Date:
April 30, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Chiara BENASSAI
Elena MOGNA
Vera MOGNA
International Classes:
A61K35/747; A61K35/74; A61K35/745; A61K36/886; A61K47/26; A61K47/36; A61K47/46; A61P31/18; A61P35/00; A61P35/02
Domestic Patent References:
JP2009269906A
JP2007084533A
JP2010534470A
Foreign References:
WO2013114185A1
WO2012143787A1
WO2013034974A1
Other References:
Cell Microbiol., 2008, Vol.10 No.7, p.1442-1452
Food Chem Toxic., 1998, Vol.36, p.1085-1094
感染症学雑誌, 1988, Vol.62 No.12, p.1105-1110
福山大学薬学部研究年報, 2002, Vol.20, p.37-63
App Microbiol Biotechnol., 2013, Vol.97, p.2109-2118
J Appl Microbiol., 2014, Vol.117, p.208-216
PNAS., 2005, Vol.102 No.8, p.2880-2885
Appl Biochem Biotechnol., 2013, Vol.169, p.511-525
Attorney, Agent or Firm:
Takuji Yamada
Aoyama Aoi
Michiko Matsutani
Sakurai Yoko